acetylcysteine has been researched along with Muscle Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Capella-Peris, C; Chrismer, IC; Cosgrove, MM; Elliott, JS; Emile-Backer, M; Kuo, A; Meilleur, KG; Razaqyar, MS; Wakim, PG | 1 |
Capella-Peris, C; Chrismer, IC; Cosgrove, MM; Elliott, JS; Emile-Backer, M; Kuo, A; Meilleur, KG; Razaqyar, MS | 1 |
Bastin, J; Bennett, MJ; Chen, J; Doulias, PT; Ischiropoulos, H; Tenopoulou, M | 1 |
Cellek, S; Minhas, S; Muneer, A; Ralph, DJ | 1 |
Arbogast, S; Brooks, SV; Dowling, JJ; Ferreiro, A; Hur, J; Kuwada, JY; Lunardi, J; Marty, I; McEvoy, A; Nelson, DD; Waugh, T | 1 |
1 trial(s) available for acetylcysteine and Muscle Disorders
Article | Year |
---|---|
Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.
Topics: Acetylcysteine; Adaptation, Psychological; Adult; Child; Double-Blind Method; Fatigue; Female; Humans; Interviews as Topic; Male; Middle Aged; Muscular Diseases; Pain; Quality of Life; Ryanodine Receptor Calcium Release Channel; Socioeconomic Factors | 2020 |
4 other study(ies) available for acetylcysteine and Muscle Disorders
Article | Year |
---|---|
Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.
Topics: Acetylcysteine; Adaptation, Psychological; Adult; Fatigue; Female; Health Status; Humans; Muscular Diseases; Quality of Life; Ryanodine Receptor Calcium Release Channel | 2020 |
Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
Topics: Acetylcysteine; Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenase, Long-Chain; Amino Acid Sequence; Carnitine; Congenital Bone Marrow Failure Syndromes; Cysteine; Dose-Response Relationship, Drug; Fatty Acids; Fibroblasts; Genetic Therapy; Humans; Kinetics; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Molecular Sequence Data; Muscular Diseases; Mutation; Oxidation-Reduction; Primary Cell Culture; Skin | 2015 |
The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcysteine; Animals; Calcium; Digoxin; Glutathione; Male; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Muscular Diseases; NG-Nitroarginine Methyl Ester; Penis; Priapism; Rabbits | 2008 |
Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.
Topics: Acetophenones; Acetylcysteine; Animals; Animals, Genetically Modified; Antioxidants; Behavior, Animal; Disease Models, Animal; Enzyme Inhibitors; Humans; Indomethacin; Larva; Microarray Analysis; Microscopy, Electron, Transmission; Mitochondria; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Diseases; Mutation; Oxidative Stress; Ryanodine Receptor Calcium Release Channel; Zebrafish | 2012 |